FDA Panel Backs Wider Use of Drug to Treat Early Stage Breast Cancer
Perjeta, which seems to shrink early stage tumors, might gain quick FDA approvalContinue Reading
Perjeta, which seems to shrink early stage tumors, might gain quick FDA approvalContinue Reading
Differences in signs, symptoms could be related to ‘beta-amyloid fibrils’ responsible for plaque, study hints
Seven tumor-specific genes appear to yield accurate prognosis, study saysContinue Reading
Finding might one day improve rates of overtreatment, undertreatment in men, study saysContinue Reading
Study shows oxytocin alters brain activity in mice; findings support ongoing trials in people with autismContinue Reading
Perjeta might gain quick FDA approvalContinue Reading
At some hospitals 1 in 4 patients returns for emergency care following colon operationContinue Reading
Study ties inherited condition that causes missing DNA to increased risk of neurological disorderContinue Reading
Discovery might lead to drugs to combat disorder that causes 325,000 U.S. deaths every yearContinue Reading
In study, electronic devices had edge over patches for people still trying to cut downContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.